Source: Medicines & Healthcare Products Regulatory Agency (GB) Revision Year: 2020 Publisher: Pfizer Limited, Ramsgate Road, Sandwich KENT, CT13 9NJ, United Kingdom
Fragmin 2500 IU.
| Pharmaceutical Form |
|---|
|
Solution for injection for subcutaneous administration. |
Active ingredient: Dalteparin sodium (INN).
Quality according to Ph.Eur. and in-house specification.
Potency is described in International anti-Factor Xa units (IU) of the 1st International Standard for Low Molecular Weight Heparin.
Content of active ingredient:
Fragmin 2500 IU: single dose syringe containing dalteparin sodium 2,500 IU (anti-Factor Xa) in 0.2 ml solution.
Fragmin syringes do not contain preservatives.
| Active Ingredient | Description | |
|---|---|---|
| Dalteparin |
Dalteparin is an antithrombotic agent, which acts mainly through its ability to potentiate the inhibition of Factor Xa and thrombin by antithrombin. It has a relatively higher ability to potentiate Factor Xa inhibition than to prolong plasma clotting time (APTT). |
| List of Excipients |
|---|
|
Sodium chloride (Ph. Eur.) |
Fragmin 2,500 IU/0.2ml solution for injection is supplied in 0.5ml glass Ph. Eur Type I single dose pre-filled syringes with a latex-free needle shield, chlorobutyl rubber, polypropylene rod and a needle-trap (safety) feature. Each pack contains 10 syringes.
Pfizer Limited, Ramsgate Road, Sandwich KENT, CT13 9NJ, United Kingdom
PL 00057/0983
18 March 2002
| Drug | Countries | |
|---|---|---|
| FRAGMIN | Austria, Brazil, Canada, Germany, Estonia, Spain, Finland, Croatia, Israel, Japan, Lithuania, Mexico, Netherlands, New Zealand, Poland, Romania, Singapore, United Kingdom, United States, South Africa |
© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.
